TABLE 1.
Characteristics of Patients With AH in the Time of COVID‐19
| Characteristic | Pre‐COVID | Declining‐COVID | P Value |
|---|---|---|---|
| Number of patients, n | 18 | 49 | |
| Median age in years (IQR) | 49 (37.5‐57.5) | 47 (39.5‐53) | 0.65 |
| Sex, female | 9 (50%) | 18 (37%) | <0.001 |
| Ethnicity | |||
| Caucasian | 15 (83%) | 24 (49%) | 0.01 |
| Hispanic | 0 | 13 (27%) | 0.01 |
| Asian‐Pacific Islander | 0 | 4 (8%) | 0.21 |
| African‐American | 2 (11%) | 6 (12%) | 0.90 |
| Unknown | 1 (6%) | 2 (4%) | |
| Drinks/day before admission, median (IQR) | 11 (5‐21.5) | 11.5 (6‐19) | 0.86 |
| Years of heavy drinking, median (IQR) | 9 (3.5‐18.5) | 10 (5‐20) | 0.46 |
| Discriminant function, median (IQR) | 62.5 (49‐87) | 80 (55‐97) | 0.09 |
| MELD‐Na on admission, median (IQR) | 32.5 (29‐35) | 34 (29‐40) | 0.24 |
| Creatinine in mg/dL, median (IQR) | 1.45 (0.6‐2.5) | 1.79 (0.91‐4.2) | 0.25 |
| Length of stay, median days (IQR) | 25 (14‐33) | 20 (10.5‐36) | 0.98 |
| Inpatient mortality rate | 7 (39%) | 14 (29%) | 0.42 |
Abbreviations: IQR, interquartile range; MELD‐Na, Model for End‐Stage Liver Disease–Sodium.